Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/18/2025
Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...
12/18/2025
Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...
12/17/2025
Hansoh and Glenmark Strike Multi-Regional Licensing Deal for EGFR Inhi...
12/17/2025
BMS Expands Antibody Pipeline Thru Global Collaboration With Harbour B...
12/17/2025
GE HealthCare Opens New R&D Center in Tianjin
12/17/2025
China Opens Consultation on First ICH M13A Low-Risk Formulation List f...
12/17/2025
CDE Solicits Comments on Draft Guidelines for Generic Ophthalmic Eye ...
12/17/2025
China Launches Pilot Program for Classified Management of Imported Foo...
12/17/2025
China's New Drug Commercial Insurance Scheme Offers Hope for Patients ...
12/16/2025
Fosun Moves to Acquire Maker of Controversial Alzheimer's Drug
12/16/2025
China Approves Genzyme's Fenthosilan Sodium Injection
12/15/2025
NHSA Unveils Three-Year Plan to Accelerate BMI Fund Clearing and Settl...
12/15/2025
Sino Biopharm Wins NMPA Approval for FIC Triple CDK Inhibitor in Breas...
12/15/2025
Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
12/15/2025
CDE Solicits Comments on First Batch of ICH M13A Low-Risk Formulation ...
12/12/2025
CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
12/12/2025
Recent Executive Moves
12/11/2025
Formation Bio Secures Global Rights to Lynk Pharma's CNS-Targeted TYK2...
12/11/2025
China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...
12/11/2025
Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
12/11/2025
Chinese Biopharma Sector Posts 22 Financings in November as In Vivo C...
12/11/2025
Innovative Drugs: The New Battleground in US-China Rivalry (ThinkChina...
12/10/2025
China Launches First Commercial Insurance Drug List, Spotlighting High...
12/10/2025
Lepu Reports Encouraging Phase II Results for CD20-Targeted ADC Combo
12/10/2025
InnoCare Highlights Strong ASH25 Data for BCL2 Inhibitor Mesutoclax
12/9/2025
Biokin Reports Strong Phase 2 Results for HER2-Targeted ADC T-Bren
12/9/2025
Embios Secures Series A Funding as It Advances CXCR3-Pathway Immunothe...
12/9/2025
Pfizer, Lilly, J&J Among First Drugmakers to Secure Spots in China's N...
12/9/2025
US Set to Tighten Curbs on Chinese Biotech and Cross-Border Investment
12/9/2025
Global Pharmas Turn to China Not Just for Assets, but for a New R&D Pl...
Page:
1
/
374
Total number of articles:
11207
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit